Eglumetad monohydrate - CAS 209216-09-1

Eglumetad (also known as LY354740) is an investigational compound developed by Eli Lilly and Company, currently under research for the treatment of anxiety disorders and substance addiction. This compound originates from glutamate, demonstrating a novel mechanism of action.

209216-09-1

C8H13NO5

203.19

C(O)(=O)[C@@]1(N)[C@@]2([C@@H](C(O)=O)[C@@]2(CC1)[H])[H].O

-20°C

Ice Packs

Small Compound